# OnCo record paper-cd30-hodgkin-lymphoma-j-clin-oncol-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cd30-hodgkin-lymphoma-j-clin-oncol-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cd30-hodgkin-lymphoma-j-clin-oncol-2020" ;
  schema:name "Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma"@en ;
  schema:description "Phase 2 or 3 results paper on CD30 in Hodgkin lymphoma, in Journal of Clinical Oncology (2020), one of the most cited Europe PMC records with CD30 in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-cd30-hodgkin-lymphoma-j-clin-oncol-2020/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.20.01342>, <https://pubmed.ncbi.nlm.nih.gov/32701411/>, <https://europepmc.org/article/MED/32701411> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.20.01342> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Ramos CA, Grover NS, Beaven AW, et al." ;
  onco:journals <https://onco.cc/journals/jco/> .